Effects of Vibration Foam Rolling After Muscle Damage
1 other identifier
interventional
32
1 country
1
Brief Summary
Purpose: To compare the effects between non-vibration foam rolling (NVFR) and vibration foam rolling (VFR) on visual analogic scale (VAS), pressure pain threshold (PPT), oxygen saturation (SmO2), counter-movement jump (CMJ), and hip and knee range of movement (ROM) after induction of muscle damage through eccentric acute-exercise using inertial flywheel. Methods: Thirty-eight healthy subjects (males n=32 females= 6, age 22.2±3.2 years) were randomly assigned in a counter-balanced fashion to either a VFR or NVFR protocol group. All subjects performed a 10x10 (sets x reps) eccentric squat protocol to induce muscle damage. The protocols were administered 48-h post-exercise, measuring VAS, PPT, SmO2, CMJ and ROM, before and immediately post-treatment. The technique of treatment was repeated on both legs for 1 min for a total of 5 sets, with a 30-s rest between sets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
July 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 7, 2018
CompletedSeptember 10, 2018
September 1, 2018
4 months
July 30, 2018
September 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
visual-analogue scale (VAS)
used to measure DOMS and to estimate the intensity of its associated pain. In order to standardize the scaling instructions, the endpoints were described for the subject as 0 = 'no sensation' and 10 = 'the most worst intense sensation imaginable' (16,40). The VAS was measured in four different conditions: 1) passive, 2) during isometric quadriceps contraction, 3) performing a squat and 4) during stretch quadriceps.
2 seconds
Pressure pain threshold
measured using a digital pressure algometer (Microfet3 ®, Hoggan Health Industries). The digital dynamometer with a 1 cm probe was used to measure three points at the quadriceps: vastus lateralis (VL), rectus femoris (RF) and vastus medialis (VM). Subject was lying on the stretcher, the algometer was positioned perpendicularly to the skin at each point and gradual pressure was applied until the subject reported a change from the sensation of pressure to pain. In that point the pressure was stopped immediately and the value was recorded represented the pain threshold (16). The mean of the 3 measures was calculated. Algometry has been shown to be highly reliable (ICC = 0.91) (9).
1 minute
Muscle oxygenation
was recorded at rest, during 10 squat repetitions (body weight load) and immediately after, using a commercially available portable non-invasive near infrared spectroscopy (NIRS) device (Moxy, Fortiori Design LLC, Minnesota, USA).
2 minutes
Secondary Outcomes (2)
Infrared Optojump photoelectric cells (Microgate Corporation, Bolzano, Italy)
5 minutes
Passive and active hip extension and knee flexion ROM of the dominant leg
2 minutes
Study Arms (2)
Foam roller
EXPERIMENTALNon-Vibration Foam Rolling (NVFR) Group: subjects performed the FR protocol using a custom-made foam roller composed of a polystyrene foam cylinder (15-cm diameter × 35-cm long).
vibration foam roller
EXPERIMENTALVibration Foam Rolling (VFR) Group: subjects performed the same protocol using a foam roller with vibration (frequency: 18 Hz) composed of a polystyrene foam cylinder (15-cm diameter × 35-cm long) (Hyperice ®).
Interventions
Eligibility Criteria
You may qualify if:
- All subjects were free from musculoskeletal disorders in the last year. All subjects were asked to abstain from unaccustomed exercise, all medications and dietary supplements 72 hours before baseline measurements, during the experimental period and post-treatment
You may not qualify if:
- Subjects with symptoms or pathology,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daniel Muñoz-Garcialead
- Camilo Jose Cela Universitycollaborator
Study Sites (1)
Centro Superior de Estudios Universitarios La Salle
Madrid, 28023, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Assessor of data was blinded to statistics investigator
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
July 30, 2018
First Posted
September 7, 2018
Study Start
January 7, 2018
Primary Completion
May 11, 2018
Study Completion
June 30, 2018
Last Updated
September 10, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share